Skip to main content

Table 1 Clinical characteristics of lung adenocarcinoma patients included in this study

From: Identification and validation of a ferroptosis-related gene to predict survival outcomes and the immune microenvironment in lung adenocarcinoma

Characteristic

TCGA-LUAD (n = 492)

GSE310219 (n = 292)

Age (%)

  ≤ 65

235(47.8)

179 (61.3)

  > 65

257(52.2)

113 (38.7)

Gender (%)

 Male

228 (46.3)

249 (85.3)

 Female

264 (53.7)

43 (14.7)

Stage (%)

 I + II

386 (78.5)

–

 III + IV

106 (21.5)

–

T(%)

 T1 + T2

427 (86.8)

235 (80.5)

 T3 + T4

62 (12.6)

52 (17.8)

 Tx

3 (0.6)

5 (1.7)

N(%)

 N0

317 (64.4)

198 (67.8)

 N1 + N2 + N3

165 (33.5)

93 (31.8)

 Nx

10 (2.0)

1 (0.3)

M(%)

 M0

328 (66.7)

281 (96.2)

 M1

25 (5.1)

8 (2.7)

 Mx

139 (28.2)

3 (1.1)